Location History:
- Jerusalem, IL (US) (2015)
- Jerusalem, IL (2014 - 2022)
Company Filing History:
3 out of 3 
2 out of 2 
1 out of 1 Years Active: 2014-2022
Title: Uriel Heresco-Levy: Innovator in Neurotransmission and Depression Treatment
Introduction
Uriel Heresco-Levy is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of neuroscience, particularly in the treatment of autoimmune disorders and major depressive disorder. With a total of 7 patents to his name, his work has the potential to impact many lives.
Latest Patents
One of Uriel's latest patents focuses on autoimmune-induced glutamatergic receptor dysfunction methods and treatments. This invention provides a method of enhancing NMDAR-mediated neurotransmission in diseases associated with NMDAR antibody production. The method involves administering an NMDAR agonist, an alanine-serine-cysteine transporter inhibitor, a D-amino acid oxidase inhibitor, a glycine transport inhibitor, or a combination thereof to the subject. Additionally, this invention offers a method for mitigating the severity of diseases associated with NMDAR antibody production through similar administration techniques.
Another significant patent addresses a dosage regimen and medication dispensing package for the treatment of major depressive disorder. This invention outlines an oral dosage regimen for depression treatment, which includes a pharmaceutically acceptable medication dispensing package containing multiple dosage units of D-cycloserine. The regimen provides a dosage of 1000 mg/day, either alone or in combination with antidepressant agents.
Career Highlights
Uriel has worked with notable institutions such as Sarah Herzog Memorial Hospital and the Ezrat Nashim Association. His experience in these organizations has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
One of Uriel's notable collaborators is Daniel C. Javitt. Their partnership has likely contributed to the advancement of research and development in their respective fields.
Conclusion
Uriel Heresco-Levy's work in neurotransmission and depression treatment showcases his dedication to improving healthcare through innovation. His patents reflect a commitment to addressing complex medical challenges, and his collaborations further enhance the impact of his contributions.